Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
Woods Hole Colloquium: The Biology of Aging

back to Woods Hole Colloquium

DNA Damage Checkpoints: P53 Regulation of the Cell Cycle

Arnold Levine

Listen to RealAudio: Lecture

Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, Princeton, NJ 08540

The P53 tumor suppresser gene product responds to DNA damage or cellular stress by being activated for transcription of several down stream genes. This results in either a G1 or G2 arrest of the cell cycle, to permit repair of the DNA, or programmed cell death. The p53 mediated response to cellular DNA damage is regulated by the genetic background of an organism, the sex of the organism and possibly by the age of the organism. Individuals who do not have a wild type p53 gene or are heterozygous for the p53 gene develop cancer at a young age (Levine, A.J., 1997, P53, the cellular gatekeeper for growth and division, Cell 88: 323-331.)

Dr. Levine has just been named President of Rockefeller University. He comes to Rockefeller from Princeton University where he was the Harry C. Weiss Professor in the Life Sciences in the Department of Molecular Biology. Dr. Levine received his B.A. from Harpur College, SUNY, and his Ph.D. from the University of Pennsylvania, School of Medicine. He was a postdoctoral fellow with Dr. Robert L. Sinsheimer at California Institute of Technology. He is a member of the National Academy of Sciences and has received numerous awards and honors throughout his career, including the G.H.A. Clowes Award from the American Association for Cancer Research (1998), The Bertner Award from the MD Anderson Cancer Center (1998), and The Paul Ehrlich and Ludwig Darmstaeder Prize from the Paul Ehrlich Foundation (1998). He is a member of the Society of Sigma Xi, the American Society for Microbiology, the American Association for Cancer Research, the American Association of Virology, and the AAAS. In 1996 he led a review of the National Institute of HealthÕs AIDS program.



Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2012 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad